SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The revenue for the March 2025 quarter is pegged at Rs. 4612.40 millions, about 15.53% up against Rs. 3992.40 millions recorded during the year-ago period.The Total Profit for the quarter ended March 2025 of Rs. 512.20 millions grew from Rs.-1149.70 millionsOperating profit for the quarter ended March 2025 rose to 810.30 millions as compared to 376.30 millions of corresponding quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 4612.40 3992.40 15.53 17357.00 14421.60 20.35 17357.00 14421.60 20.35
Other Income 60.50 70.40 -14.06 408.30 303.90 34.35 408.30 303.90 34.35
PBIDT 810.30 376.30 115.33 2947.10 813.00 262.50 2947.10 813.00 262.50
Interest 15.30 17.60 -13.07 76.20 104.20 -26.87 76.20 104.20 -26.87
PBDT 835.00 -897.50 -193.04 2910.90 132.70 2093.59 2910.90 132.70 2093.59
Depreciation 274.70 252.20 8.92 1084.10 1054.50 2.81 1084.10 1054.50 2.81
PBT 560.30 -1149.70 -148.73 1826.80 -921.80 -298.18 1826.80 -921.80 -298.18
TAX 48.10 0.00 0.00 197.20 0.00 0.00 197.20 0.00 0.00
Deferred Tax 48.10 0.00 0.00 197.20 0.00 0.00 197.20 0.00 0.00
PAT 512.20 -1149.70 -144.55 1629.60 -921.80 -276.78 1629.60 -921.80 -276.78
Equity 140.80 140.80 0.00 140.80 140.80 0.00 140.80 140.80 0.00
PBIDTM(%) 17.57 9.43 86.39 16.98 5.64 201.19 16.98 5.64 201.19

Unichem Lab Share Price

350.85 4.85 (1.40%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×